business performance, such as total gross margin of complete (bio)pharma markets solution portfolios, return on investment...-to-money of newly launched solutions. In this case, the fist assignment will be peptides and oligonucleotides (TIDES). He...
Bruker-to-money of newly launched solutions. In this case, the fist assignment will be peptides and oligonucleotides (TIDES). He... business model. Pro-actively participate in the (bio)pharma market strategy development and execution process...
Brukerbusiness performance, such as total gross margin of complete (bio)pharma markets solution portfolios, return on investment...-to-money of newly launched solutions. In this case, the fist assignment will be peptides and oligonucleotides (TIDES). He...
Bruker